Rhonda A Longmore Grund Net Worth

The estimated Net Worth of Rhonda A Longmore Grund is at least $86.7 Thousand dollars as of 19 May 2016. Rhonda Grund owns over 2,500 units of Global X Funds stock worth over $86,650 and over the last 9 years Rhonda sold AIQ stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Rhonda Grund AIQ stock SEC Form 4 insiders trading

Rhonda has made over 1 trades of the Global X Funds stock since 2016, according to the Form 4 filled with the SEC. Most recently Rhonda bought 2,500 units of AIQ stock worth $18,975 on 19 May 2016.

The largest trade Rhonda's ever made was buying 2,500 units of Global X Funds stock on 19 May 2016 worth over $18,975. On average, Rhonda trades about 625 units every 0 days since 2016. As of 19 May 2016 Rhonda still owns at least 2,500 units of Global X Funds stock.

You can see the complete history of Rhonda Grund stock trades at the bottom of the page.

What's Rhonda Grund's mailing address?

Rhonda's mailing address filed with the SEC is C/O ALLIANCE HEALTHCARE SERVICES, INC., 100 BAYVIEW CIRCLE, SUITE 400, NEWPORT BEACH, CA, 92660.

Insiders trading at Global X Funds

Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene, and Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.

What does Global X Funds do?

Complete history of Rhonda Grund stock trades at Global X Funds

Global X Funds executives and stock owners

Global X Funds executives and other stock owners filed with the SEC include:

• R Brian Hanson,
  Executive VP & CFO
• Russell D Jr Phillips,
  EVP, Gen.Coun.,Secre.
• Henry R Kravis,
  Director
• Kenneth S Ord,
  Executive VP & CFO
• Rhonda A Longmore Grund,
  EVP and CFO
• Heping Feng,
  
• Tao L. Zhang,
  
• Edward L Samek,
  Director
• Richard A. Jones,
  Executive Vice President
• Neil F Dimick,
  Director
• Paul S Viviano,
  Chairman, President & CEO
• Richard W Johns,
  EVP, General Counsel & Sec.
• Percy C Jr Tomlinson,
  President & CEO
• Gregory E. Spurlock,
  President. Alliance Oncology
• Christianna S Rosow,
  Principal Accounting Officer
• Scott A Bartos,
  Director
• Larry C. Buckelew,
  Director
• Howard K Aihara,
  VP & Corporate Controller
• Deborah Rodriguez,
  EVP, Human Resources
• Michael J Shea,
  Chief Operating Officer
• Nicholas A Poan,
  VP, Corporate Controller
• Eli H Glovinsky,
  Exec.VP,Gen.Coun,Corp.Secre.
• Michael F Frisch,
  Executive Vice President & COO
• Richard J Hall,
  President, Alliance Oncology
• Curtis Lane,
  Director
• Christopher J Joyce,
  Executive Vice President, M&A
• Aaron Bendikson,
  Director
• Health Investors Ii, Lp All...,
  
• Anthony B Helfet,
  Director
• Principal Opportunities Fun...,
  
• Michael P Harmon,
  Director
• Health Investors Ii, Lp All...,
  
• Alexandar Jrraether Paul Er...,
  
• James C Momtazee,
  Director
• Michael W Michelson,
  Director
• Kenneth W/Nj Freeman,
  Director
• 1996 Gp Llckkr Associates 1...,
  
• James H Jr Greene,
  Director
• Adam Clammer,
  Director
• Andrew P Hayek,
  Executive VP & COO